P-204: In-class transition (iCT) from parenteral bortezomib to oral ixazomib therapy in newly diagnosed multiple myeloma (NDMM) patients (pts): fully accrued data from the communitybased US MM-6 study

Authors :: Habte Yimer
Ruemu Birhiray
Ralph Boccia
Sudhir Manda
Suman Kambhampati
Joshua Richter
Jack Aiello
Saulius Girnius
Dasha Cherepanov
Kim Tran
Presley Whidden
Stephen Noga
Robert Rifkin
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S147-S148
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools